CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.5600
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT

HKG:0775 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,4105,4105,5235,3235,2765,402
Revenue Growth
-1.50%-2.04%3.76%0.89%-2.35%9.30%
Gross Profit
1,5771,5771,6931,6371,6261,630
Operating Income
-131.03-131.0377.46223.85239.92236.61
Net Income
-186.81-186.81-126.5517.25131.96162.8
Earnings Per Share
-0.02-0.02-0.010.000.010.02
EPS Growth
----86.93%-18.94%30.29%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Agriculture-Related
2,0372,0372,0702,0792,1782,279
Nutraceuticals
3,3723,3723,4523,2433,0973,122
Unallocated
1.411.411.341.170.821.38
Total
5,4105,4105,5235,3235,2765,402

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
603.07603.07571.21676.16704.13902.47
Total Debt
6,6216,6216,1005,9315,9466,213
Net Cash (Debt)
-6,018-6,018-5,528-5,255-5,242-5,311
Net Cash Growth
------
Net Cash Per Share
-0.63-0.63-0.58-0.55-0.55-0.55

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
186.95186.95353.53514.18363.66423.58
Capital Expenditures
-244.98-244.98-196.53-287.68-216.02-216.2
Free Cash Flow
-58.03-58.03157.01226.51147.64207.37
Free Cash Flow Growth
---30.68%53.41%-28.80%6.06%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
29.15%29.15%30.65%30.76%30.82%30.17%
Operating Margin
-2.42%-2.42%1.40%4.21%4.55%4.38%
Pretax Margin
-0.33%-0.33%-1.66%1.29%3.88%4.41%
Profit Margin
-3.45%-3.45%-2.29%0.32%2.50%3.01%
FCF Margin
-1.07%-1.07%2.84%4.25%2.80%3.84%

Dividends

Fiscal YearFY 2022FY 2021
Period EndingDec '22 Dec '21
Dividend Per Share
0.0080.010
Dividend Per Share Growth
-20.00%0%
Dividend Yield
1.02%1.39%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---345.4457.5443.69
Forward PE
-13.7513.7513.7513.7513.75
P/FCF Ratio
--25.1026.3151.4334.30
PS Ratio
0.991.460.711.121.441.32